Neuropsychological Outcomes in Adult Patients and Survivors of COVID-19
Open Access
- 14 April 2022
- Vol. 11 (4), 465
- https://doi.org/10.3390/pathogens11040465
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is believed to affect central nervous system functions through various indirect, and possibly direct, mechanisms. We are only now beginning to understand the possible effects of the virus on human cognition. This review summarizes extant yet limited literature on clinical neuropsychological findings in adult coronavirus disease 2019 (COVID-19) patients and survivors. Neuropsychological outcomes were often in the form of cognitive screen results, although various studies administered comprehensive batteries. With respect to screens, the Montreal Cognitive Assessment appeared relatively sensitive to cognitive dysfunction associated with COVID-19. Patients and survivors presented with weaknesses on screens and comprehensive batteries, although the pattern of these weaknesses was not specific to etiology. Broadly, weaknesses were suggestive of executive dysfunction, although more than one study did not detect significant impairment. Weaknesses should be interpreted cautiously due to potential confounds/contributing factors (weaknesses may partly reflect psychiatric sequelae; weaknesses may be over-interpreted due to inadequate assessment of premorbid functioning). Studies reported different approaches in defining impairment, likely contributing to variable findings. The current review discusses ongoing efforts to harmonize approaches to evaluating neuropsychological functioning globally, as well as emphasizes taking a comprehensive approach towards understanding how the disease affects cognition.This publication has 40 references indexed in Scilit:
- Pattern of cognitive deficits in severe COVID-19Journal of Neurology, Neurosurgery & Psychiatry, 2020
- COVID-19 and stroke: A reviewBrain Hemorrhages, 2020
- Cognitive profile following COVID-19 infection: Clinical predictors leading to neuropsychological impairmentBrain, Behavior, & Immunity - Health, 2020
- Neuropsychology in the Times of COVID-19. The Role of the Psychologist in Taking Charge of Patients With Alterations of Cognitive FunctionsFrontiers in Neurology, 2020
- Unraveling the Possible Routes of SARS-COV-2 Invasion into the Central Nervous SystemCurrent Treatment Options in Neurology, 2020
- COVID-19 and clinical neuropsychology: A review of neuropsychological literature on acute and chronic pulmonary diseaseThe Clinical Neuropsychologist, 2020
- Potential neuroinvasive pathways of SARS‐CoV‐2: Deciphering the spectrum of neurological deficit seen in coronavirus disease‐2019 (COVID‐19)Journal of Medical Virology, 2020
- The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive ImpairmentJournal of the American Geriatrics Society, 2005
- The FABNeurology, 2000
- “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinicianJournal of Psychiatric Research, 1975